Animal & Veterinary
FDA Offers Workshop on Swine Mycoplasmal Pneumonia
FDA Veterinarian Newsletter 2002 Volume XVII, No II
The Food and Drug Administration (FDA) is holding a Swine Mycoplasmal Pneumonia Technical Workshop. The topic to be discussed at this public workshop is how to evaluate drug effectiveness against swine mycoplasmal respiratory disease.
The public workshop will be held on March 6 and 7, 2002, at the DoubleTree Hotel Kansas City, 1301 Wyandotte St., Kansas City, MO 64105, 816-474-6664. The workshop will be held from 8:30 a.m. to 5:00 p.m. on Wednesday, March 6 and from 7:00 a.m. to 3:30 p.m. on Thursday, March 7.
FDA is seeking scientific input from a broad public forum to help the Agency determine an acceptable method, in light of the current state of scientific knowledge, for evaluating drug effectiveness against swine mycoplasmal respiratory disease. Mycoplasma hyopneumoniae is a major pathogen in "porcine respiratory disease complex" (PRDC). PRDC is a significant problem in the swine industry in the United States and abroad. This workshop will provide a necessary forum for leveraging scientific resources, including top experts in swine mycoplasmal pneumonia. The workshop is part of CVM's leveraging initiative aimed at increasing interaction with industry, academia, practitioners, and other government agencies.
Registration is required for the meeting, and space is limited. Registration will be on a first come, first served basis, and there is no registration fee. Electronic registration for the workshop is available at (see Docket No. 02N-0027.) Alternatively, please send registration information (including name, title, firm name, address, telephone, and fax number) to Irma Carpenter, Center for Veterinary Medicine (HFV-130), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301-827-7580, FAX 301-594-2298. If you need special accommodations due to a disability, please contact the DoubleTree Hotel Kansas City at least seven days in advance at 816-474-6664 and Irma Carpenter at 301-827-7580.
Written or electronic comments on this workshop may be submitted by May 6, 2002, to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Submit electronic comments to http://www.accessdata.fda.gov/scripts/oc/dockets/comment docket.cfm. All comments should include Docket No. 02N-0027.
Additional information about the workshop, including a preliminary agenda, is contained in the February 6, 2002, Federal Register. For general information about the workshop, contact: Dr. Gillian A. Comyn, Center for Veterinary Medicine (HFV-135), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301-827-7568, FAX 301-594-2298. As it becomes available, additional information about the workshop will be posted on the Internet at the Center for Veterinary Medicine (CVM) Web site.